Reta 20mg research peptide

Retatrutide is a novel investigational peptide designed as a triple agonist, targeting the GLP-1, GIP, and glucagon receptors. It is currently being studied for its potential to support metabolic regulation, with promising early data on weight management, 

Retatrutide – 20mg (Research-Grade Peptide)
Triple Agonist: GLP-1 / GIP / Glucagon Receptors
For Research Use Only

Retatrutide is a cutting-edge investigational peptide designed as a triple receptor agonist, simultaneously targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This unique mechanism positions Retatrutide as a promising compound in the study of metabolic disorders, body weight regulation, and glucose homeostasis.

In preclinical and early clinical research, Retatrutide has demonstrated potential to:

• Enhance insulin sensitivity and glucose control

• Promote significant fat loss through appetite regulation and increased energy expenditure

• Support lean body mass retention during caloric restriction

• Improve metabolic markers linked to obesity and type 2 diabetes

This product is supplied as a lyophilized powder for laboratory research purposes only. It is not intended for human or animal consumption, nor for therapeutic or diagnostic use.

Storage:Reconstitute using bacteriostatic or sterile water for research applications.

once mixed keep refrigerated 

comes with a 3ml vial of bac water 

 batch  RET20-3/06/25